Data / Form D filings / Greyledge Technologies, Inc.
Greyledge Technologies, Inc.: Form D filings
Greyledge Technologies, Inc., a biotechnology company in Lone Tree, CO, filed 3 Form D notices with the SEC between 2022 and 2023. The latest, on May 9, 2023, reports $4.3 million sold of a $4.3 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10101 RIDGEGATE PARKWAY, SUITE G-01, Lone Tree, CO, 80124
- Phone
- (757) 635-1311
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1840347
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 9, 2023 | Amendment | $4,336,100 | $4,336,052 | $48 | 17 | Mar 11, 2022 | sec.gov |
| May 20, 2022 | Amendment | $3,000,000 | $2,700,000 | $300,000 | 17 | Mar 11, 2022 | sec.gov |
| Apr 4, 2022 | New notice | $3,000,000 | $1,525,000 | $1,475,000 | 9 | Mar 11, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Karli | Executive Officer, Director | |
| Zoe Bedford Karli | Executive Officer, Director |
Other biotechnology companies in Colorado that filed recently
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
- Shiverbright Technologies, Inc. $200,000 · Aug 7, 2026
Every Form D from the week of May 8, 2023 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Greyledge Technologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.